ACSL3 and non-small cell lung carcinoma: Survival analysis based on the TCGA-NSCLC dataset showed that the survival of patients with high PHKG2 expression was significantly better than that of patients with low PHKG2 expression, while the relationship between ACSL3 expression and patient survival was not significant (Fig. 1G, Supplementary Fig. 3C).